| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1 Pharmacology, Physiology, and Therapeutics and 2 Chemistry, University of North Dakota, Grand Forks, North Dakota 58203; and 3 Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202
Alcoholic cardiomyopathy is characterized by impaired ventricular function although its toxic mechanism is unclear. This study examined the impact of cardiac overexpression of alcohol dehydrogenase (ADH), which oxidizes ethanol into acetaldehyde (ACA), on ethanol-induced cardiac contractile defect. Mechanical and intracellular Ca2+ properties were evaluated in ventricular myocytes from ADH transgenic and wild-type (FVB) mice. ACA production was assessed by gas chromatography. ADH myocytes exhibited similar mechanical properties but a higher efficiency to convert ACA compared with FVB myocytes. Acute exposure to ethanol depressed cell shortening and intracellular Ca2+ in the FVB group with maximal inhibitions of 23.3% and 23.4%, respectively. Strikingly, the ethanol-induced depression on cell shortening and intracellular Ca2+ was significantly augmented in the ADH group, with maximal inhibitions of 43.7% and 40.6%, respectively. Pretreatment with the ADH inhibitor 4-methylpyrazole (4-MP) or the aldehyde dehydrogenase inhibitor cyanamide prevented or augmented the ethanol-induced inhibition, respectively, in the ADH but not the FVB group. The ADH transgene also substantiated the ethanol-induced inhibition of maximal velocity of shortening/relengthening and unmasked an ethanol-induced prolongation of the duration of shortening/relengthening, which was abolished by 4-MP. These data suggest that elevated cardiac ACA exposure due to enhanced ADH expression may play an important role in the development of alcoholic cardiomyopathy.
transgene; acetaldehyde; shortening; intracellular calcium ion transient
This article has been cited by other articles:
|
|
 |
|
  T. Oba, Y. Maeno, M. Nagao, N. Sakuma, and T. Murayama Cellular redox state protects acetaldehyde-induced alteration in cardiomyocyte function by modifying Ca2+ release from sarcoplasmic reticulum Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H121 - H133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, S. Wu, S.-Y. Li, F. L. Lopez, M. Du, J. Kajstura, P. Anversa, and J. Ren Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1398 - H1403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, F. Dong, Q. Li, A. J. Borgerding, A. L. Klein, and J. Ren Cardiac overexpression of catalase antagonizes ADH-associated contractile depression and stress signaling after acute ethanol exposure in murine myocytes J Appl Physiol, December 1, 2005; 99(6): 2246 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. MacGowan, J. Rager, S. G. Shroff, and M. A. Mathier In vivo {alpha}-adrenergic responses and troponin I phosphorylation: anesthesia interactions J Appl Physiol, April 1, 2005; 98(4): 1163 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Oba and Y. Maeno Acetaldehyde alters Ca2+-release channel gating and muscle contraction in a dose-dependent manner Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1188 - C1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Duan, H.-Y. Zhang, S. D. Adkins, B. H. Ren, F. L. Norby, X. Zhang, J. N. Benoit, P. N. Epstein, and J. Ren Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E366 - E376. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
